Rock Springs Capital Management LP Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$4.3B
Holdings
136
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (136 positions)
| Stock | Value |
|---|---|
AGLAGILON HEALTH INC | $202.4M |
HUMHUMANA INC | $161.9M |
AFWALIGN TECHNOLOGY INC | $131.4M |
ISRGINTUITIVE SURGICAL INC | $129.3M |
PODDINSULET CORP | $123.4M |
UNHUNITEDHEALTH GROUP INC | $120.5M |
IDXXIDEXX LABS INC | $118.5M |
HCAHCA HEALTHCARE INC | $115.6M |
ARGXARGENX SE | $110.3M |
NBIXNEUROCRINE BIOSCIENCES INC | $94.1M |
2L9BLUEPRINT MEDICINES CORP | $92.1M |
AGIOAGIOS PHARMACEUTICALS INC | $87.0M |
IMCRIMMUNOCORE HLDGS PLC | $84.6M |
HZNPHORIZON THERAPEUTICS PUB L | $80.4M |
EWEDWARDS LIFESCIENCES CORP | $75.4M |
RAREULTRAGENYX PHARMACEUTICAL IN | $74.3M |
ZLABZAI LAB LTD | $74.2M |
BAXBAXTER INTL INC | $63.0M |
NVV1NOVAVAX INC | $60.8M |
MRTXEURMIRATI THERAPEUTICS INC | $60.2M |
PCRXPACIRA BIOSCIENCES INC | $60.2M |
NVROEURNEVRO CORP | $57.9M |
EVHEVOLENT HEALTH INC | $56.4M |
ALNYALNYLAM PHARMACEUTICALS INC | $56.4M |
ACRSACLARIS THERAPEUTICS INC | $56.1M |
KRTXKARUNA THERAPEUTICS INC | $55.9M |
FRPTFRESHPET INC | $55.3M |
ASNDASCENDIS PHARMA A/S | $53.8M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $53.4M |
IRTCIRHYTHM TECHNOLOGIES INC | $51.0M |
KYMRKYMERA THERAPEUTICS INC | $47.1M |
ACHCACADIA HEALTHCARE COMPANY IN | $45.4M |
EXASEXACT SCIENCES CORP | $44.4M |
NVTA1EURINVITAE CORP | $42.8M |
PENPENUMBRA INC | $42.7M |
SWAVUSDSHOCKWAVE MED INC | $39.7M |
SGENUSDSEAGEN INC | $39.6M |
SRPTSAREPTA THERAPEUTICS INC | $38.2M |
ARVNARVINAS INC | $37.6M |
CYTK 4 11/15/26CYTOKINETICS INC | $35.7M |
WRBYWARBY PARKER INC | $33.7M |
HCATHEALTH CATALYST INC | $33.7M |
VERVVERVE THERAPEUTICS INC | $33.3M |
CVETUSDCOVETRUS INC | $33.2M |
EHCENCOMPASS HEALTH CORP | $32.8M |
PHRPHREESIA INC | $32.1M |
PRTAPROTHENA CORP PLC | $32.0M |
ACCDEURACCOLADE INC | $31.6M |
DC4DEXCOM INC | $30.5M |
TVTXTRAVERE THERAPEUTICS INC | $29.5M |
—ABCAM PLC | $29.5M |
CNMDCONMED CORP | $28.7M |
GRPHGRAPHITE BIO INC | $25.8M |
—SIERRA ONCOLOGY INC | $25.8M |
—INTERSECT ENT INC | $25.7M |
MIRMMIRUM PHARMACEUTICALS INC | $24.5M |
—PROMETHEUS BIOSCIENCES INC | $24.5M |
XENEXENON PHARMACEUTICALS INC | $24.1M |
BMRNBIOMARIN PHARMACEUTICAL INC | $23.3M |
MDGLMADRIGAL PHARMACEUTICALS INC | $22.8M |
LUNGPULMONX CORP | $22.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $22.2M |
WSTWEST PHARMACEUTICAL SVSC INC | $21.3M |
—MERSANA THERAPEUTICS INC | $20.2M |
GHGUARDANT HEALTH INC | $20.0M |
XLOXILIO THERAPEUTICS INC | $19.1M |
LFSTLIFESTANCE HEALTH GROUP INC | $19.0M |
LEGNLEGEND BIOTECH CORP | $18.8M |
ANABANAPTYSBIO INC | $18.7M |
RLAYRELAY THERAPEUTICS INC | $18.4M |
IMRXIMMUNEERING CORP | $17.6M |
AURAAURA BIOSCIENCES INC | $17.1M |
CMPXCOMPASS THERAPEUTICS INC | $16.9M |
—ICOSAVAX INC | $16.8M |
SPROSPERO THERAPEUTICS INC | $15.1M |
GOSS 5 06/01/27GOSSAMER BIO INC | $15.1M |
AMRNAMARIN CORP PLC | $14.9M |
—AMRYT PHARMA PLC | $14.1M |
MGNXMACROGENICS INC | $13.8M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $13.5M |
NVCRNOVOCURE LTD | $13.1M |
WHWKAADI BIOSCIENCE INC | $13.0M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $12.9M |
AKROAKERO THERAPEUTICS INC | $12.4M |
290ACHINOOK THERAPEUTICS INC | $11.7M |
AM6AMICUS THERAPEUTICS INC | $11.7M |
LPTXEURLEAP THERAPEUTICS INC | $11.4M |
ABOSACUMEN PHARMACEUTICALS INC | $10.6M |
AUPHAURINIA PHARMACEUTICALS INC | $10.5M |
CGEMCULLINAN ONCOLOGY INC | $10.0M |
—ORION ACQUISITION CORP | $9.8M |
OKURRENEO PHARMACEUTICALS INC | $9.8M |
—EPIZYME INC | $9.5M |
—OLINK HLDG AB | $9.4M |
NRIXNURIX THERAPEUTICS INC | $9.3M |
MREOMEREO BIOPHARMA GROUP PLC | $8.9M |
BMEABIOMEA FUSION INC | $8.7M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $8.3M |
—VINCERX PHARMA INC | $8.2M |
FULCFULCRUM THERAPEUTICS INC | $8.1M |
Page 1 of 2Next